Summary:
The clinical significance of early airflow decline after myeloablative allogeneic hematopoietic SCT is uncertain. We performed a retrospective cohort analysis to determine if airflow decline by day 100 is associated with later development of transplant-related airflow obstruction (AFO) and increased mortality risk. Overall, 750 (40%) patients had airflow decline by day 100. Development of airflow decline by day 100 was associated with an increased risk for AFO at 1 year (relative risk 2.6, 95% confidence interval 2.1–3.1) but not with an increase in mortality risk (hazard ratio (HR) 0.86, P=0.05). However, patients with the fastest rate of decline between day 100 and 1 year (12.5% per year ±24) had the highest mortality risk (HR 3.2, P<0.001). In conclusion, airflow measurements made on day 100 do not predict the rate of airflow decline between day 100 and 1 year, and therefore are not useful as a single measurement for determining mortality risk associated with development of AFO. Closer monitoring of the rate of airflow decline during the first year may facilitate the timely detection and treatment of early airflow decline and prevent the development of fixed AFO and increased mortality risk after hematopoietic stem cell transplant.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chien JW, Martin PJ, Gooley TA et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168: 208–214.
Tait RC, Burnett AK, Robertson AG et al. Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: relationship to total body irradiation and graft-versus-host disease. Int J Radiat Oncol Biol Phys 1991; 20: 1219–1227.
Beinert T, Dull T, Wolf K et al. Late pulmonary impairment following allogeneic bone marrow transplantation. Eur J Med Res 1996; 1: 343–348.
Schwarer AP, Hughes JM, Trotman-Dickenson B, Krausz T, Goldman JM . A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation 1992; 54: 1002–1008.
Duncker C, Dohr D, Harsdorf S et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome. Bone Marrow Transplant 2000; 25: 1263–1268.
Chan CK, Hyland RH, Hutcheon MA et al. Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine (Baltimore) 1987; 66: 327–340.
Curtis DJ, Smale A, Thien F, Schwarer AP, Szer J . Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 169–173.
Clark JG, Schwartz DA, Flournoy N, Sullivan KM, Crawford SW, Thomas ED . Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987; 107: 648–656.
Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.
Griese M, Rampf U, Hofmann D, Fuhrer M, Reinhardt D, Bender-Gotze C . Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 2000; 30: 393–401.
Paz HL, Crilley P, Patchefsky A, Schiffman RL, Brodsky I . Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 1992; 101: 775–778.
Clark JG, Crawford SW, Madtes DK, Sullivan KM . Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989; 111: 368–376.
Philit F, Wiesendanger T, Archimbaud E, Mornex JF, Brune J, Cordier JF . Post-transplant obstructive lung disease (‘bronchiolitis obliterans’): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 1995; 8: 551–558.
Palmas A, Tefferi A, Myers JL et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998; 100: 680–687.
Sanchez J, Torres A, Serrano J et al. Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 20: 403–408.
Hsu KH, Jenkins DE, Hsi BP et al. Ventilatory functions of normal children and young adults – Mexican-American, white, and black. I. Spirometry. J Pediatr 1979; 95: 14–23.
Crapo RO, Morris AH, Gardner RM . Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659–664.
Folz RJ . Allogeneic stem cell transplant, lung disease, and airflow obstruction. Am J Respir Crit Care Med 2003; 168: 146–147.
Koc S, Leisenring W, Flowers ME et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 2002; 100: 48–51.
Sullivan K . Graft-versus-host disease. In: Thomas E, Blume K, Forman S (eds). Henatopoietic Stem Cell Transplantation,, 2nd edn. Blackwell Science: Malden, MA, 1999, pp 518–519.
Przepiorka D, Smith TL, Folloder J et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999; 94: 1465–1470.
Sullivan KM, Shulman HM, Storb R et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267–276.
Nichols WG, Gooley T, Boeckh M . Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biol Blood Marrow Transplant 2001; 7: 11S–15S.
Nichols WG, Corey L, Gooley T, Davis C, Boeckh M . Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 2001; 98: 573–578.
Zhang J, Yu KF . What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280: 1690–1691.
Kaplan E, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
Ralph DD, Springmeyer SC, Sullivan KM, Hackman RC, Storb R, Thomas ED . Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease. Am Rev Respir Dis 1984; 129: 641–644.
Ostrow D, Buskard N, Hill RS, Vickars L, Churg A . Bronchiolitis obliterans complicating bone marrow transplantation. Chest 1985; 87: 828–830.
Johnson FL, Stokes DC, Ruggiero M, Dalla-Pozza L, Callihan TR . Chronic obstructive airways disease after bone marrow transplantation. J Pediatr 1984; 105: 370–376.
Epler GR, Colby TV . The spectrum of bronchiolitis obliterans. Chest 1983; 83: 161–162.
Badier M, Guillot C, Delpierre S, Vanuxem P, Bla ise D, Maraninchi D . Pulmonary function changes 100 days and one year after bone marrow transplantation. Bone Marrow Transplant 1993; 12: 457–461.
Acknowledgements
Financial support for this study was received from NIH Grants T32 HL07287, PO1 CA 18029, HL36444, CA18221, 1R01 HL71914-01, 1K23HL69860-01, American Lung Association of Washington Research Grant.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chien, J., Martin, P., Flowers, M. et al. Implications of early airflow decline after myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 33, 759–764 (2004). https://doi.org/10.1038/sj.bmt.1704422
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704422
Keywords
This article is cited by
-
The predictive value of pulmonary function test before transplantation for chronic pulmonary graft-versus-host-disease after allogeneic hematopoietic stem cell transplantation
BMC Pulmonary Medicine (2022)
-
Decline of forced expiratory volume in 1 s after allogeneic hematopoietic cell transplantation is a good indicator for pulmonary damage and is associated with busulfan use
International Journal of Hematology (2019)
-
A retrospective multi-centre study of the effects of allogeneic haematopoietic SCT on pulmonary function
Bone Marrow Transplantation (2014)
-
What we know and mostly do not know about bronchiolitis obliterans syndrome
Bone Marrow Transplantation (2012)
-
Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation
Bone Marrow Transplantation (2008)